639 filings
Page 2 of 32
8-K
6uhqz75cmggq
14 Aug 23
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim
4:16pm
8-K
g3ih9ohrogzz0rmd
5 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
yzq6fcwprr5ko
12 Jun 23
Material Modifications to Rights of Security Holders
4:15pm
8-K
6n3d8e2eo95
10 May 23
Alaunos Therapeutics Reports First Quarter 2023 Financial Results
7:09am
DEFA14A
hia41c
25 Apr 23
Additional proxy soliciting materials
5:06pm
8-K
nwxv 6fp3
4 Apr 23
Entry into a Material Definitive Agreement
5:11pm
8-K
mymju 8pednz9a
3 Apr 23
Entry into a Material Definitive Agreement
8:00am
8-K
gfr7y4rvuyqp6uz8
30 Mar 23
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors
7:41am
8-K
wx9s49ixo5wqk5un8
7 Mar 23
Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
7:07am
8-K
v1018 yyv7ils6m9a6d
9 Jan 23
Regulation FD Disclosure
8:38am
8-K
24usi5hyrsly ha
4 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:52pm
8-K
lnto6r6w
30 Nov 22
Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
5:10pm
424B5
e5o7gdeuhe pseq9k88
30 Nov 22
Prospectus supplement for primary offering
5:09pm
424B5
yelo7 f41td0es4rn
28 Nov 22
Prospectus supplement for primary offering
4:07pm
8-K
pufjy3fs51k8rcx gq
14 Nov 22
Alaunos Therapeutics Reports Third Quarter 2022 Financial Results
7:06am